European recommendation for APL

European recommendation for salvage therapy of relapsed acute promyelocytic leukemia (APL) including arsenic trioxide (ATO)

Author: PD Dr. Eva Lengfelder, Med. Fakultät Mannheim, Heidelberg University, Germany

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

Sanz, M. A., Fenaux, P., Tallman, M. S., Estey, E. H., Löwenberg, B., Naoe, T., ... & Lo-Coco, F. (2019). Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood,133(15), 1630-1643 (772KB)

Guidelines

Recommendations: Relapsed APL (312KB)

Recommendations_relapsed_APL_12122007

About us

The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care and cure.

European recommendation for APL

About us

Lastest Posts

Links

Kontakt-Info